FundedIQ
Biotechnology

MindMed: Funding, Investors & Team (Oct 2026)

MindMed offers treatments and therapies for substance abuse disorders and mental illnesses that are inspired by psychedelics. The company is developing a range of innovative drugs based on substances like Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative called 18-MC.

www.mindmed.co LinkedIn New York, United States 101-250 employees
Total raised
$265M
Rounds
3
Latest
Undisclosed round
Aug 2024

MindMed has raised $265M across 3 funding rounds on record, the most recent an undisclosed round of $75.0M announced in Aug 2024.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

MindMed Company Profile and Key Stats

Total funding raised
$265M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$75.0M in Aug 2024
Employees
101-250
reported band
Headquarters
New York, United States

Latest funding round on record: Aug 2024.

MindMed Funding Rounds

Date
Round
Amount
Undisclosed round
$75.0M
Undisclosed round
$175M
Undisclosed round
$15.0M

MindMed raised $15.0M in an undisclosed round announced in Aug 2023.

7 months later, an undisclosed round of $175M was announced in Mar 2024.

5 months later, an undisclosed round of $75.0M was announced in Aug 2024.

MindMed Founders and Leadership Team

Name
Role
Contact
Leonard Latchman
Founder
—
Robert Barrow
Founder
Locked

Contact details for the MindMed team: 1 of 2 have an email address on file.

Start 14-day free trial →

MindMed Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

MindMed's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like MindMed in Biotechnology and New York

Companies Similar to MindMed

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

MindMed Funding FAQs

What does MindMed do?

MindMed offers treatments and therapies for substance abuse disorders and mental illnesses that are inspired by psychedelics. The company is developing a range of innovative drugs based on substances like Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative called 18-MC.

How much funding has MindMed raised?

MindMed has raised $265M across 3 rounds on record. The most recent is an undisclosed round of $75.0M announced in Aug 2024.

When did MindMed last raise funding?

MindMed's most recent funding round on record is an undisclosed round of $75.0M, announced in Aug 2024.

Who founded MindMed?

FundedIQ lists Leonard Latchman (Founder), Robert Barrow (Founder) at MindMed.

Where is MindMed headquartered?

MindMed is based in New York, United States.

How many employees does MindMed have?

MindMed is in the 101-250 employee band.

How does MindMed's funding compare to other Biotechnology startups?

MindMed's latest round of $75.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's MindMed Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MindMed is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.